<table id="id_7d68dbc8-31f6-42ec-bf06-528791934424" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<thead>
<tr id="id_5e0af525-ff5f-4338-92f5-6694728920b5" stylecode="Toprule">
<td align="center" colspan="3" stylecode="Botrule" valign="top"> <content stylecode="bold">Table 7. Erosive Esophagitis Patient Healing Rates </content>
</td>
</tr>
<tr id="id_f878eeb1-71ee-43a1-b2d9-2644be814a4c">
<td align="left" stylecode="Botrule Rrule" valign="top"> </td>
<td align="center" colspan="2" stylecode="Botrule" valign="top">  Healed / Evaluable </td>
</tr>
<tr id="id_71260512-27d3-483c-b76a-a56b9c410fcb" stylecode="Botrule">
<td align="left" stylecode="Botrule Rrule" valign="top"> </td>
<td align="center" stylecode="Botrule Rrule" valign="top">  Placebo* <br/>n=229 </td>
<td align="center" stylecode="Botrule" valign="top">  Ranitidine Tablets, USP<br/>150 mg q.i.d.*<br/>n=215 </td>
</tr>
</thead>
<tbody>
<tr id="id_b0eaa07d-4e0b-4a36-8409-6b8a2a5e1b2b" stylecode="Toprule">
<td align="left" stylecode="Botrule Rrule" valign="top"> Week 4</td>
<td align="center" stylecode="Botrule Rrule" valign="top"> 43/198 (22%)</td>
<td align="center" stylecode="Botrule" valign="top"> 96/206 (47%) <sup>†</sup>
</td>
</tr>
<tr id="id_ac855f38-6fa5-457f-9e35-b2a64e3e5e14">
<td align="left" stylecode="Botrule Rrule" valign="top"> Week 8</td>
<td align="center" stylecode="Botrule Rrule" valign="top"> 63/176 (36%)</td>
<td align="center" stylecode="Botrule" valign="top"> 142/200 (71%) <sup>†</sup>
</td>
</tr>
<tr id="id_987966fa-aae5-4fff-a876-895a45ee5959" stylecode="Botrule">
<td align="left" stylecode="Rrule" valign="top"> Week 12</td>
<td align="center" stylecode="Rrule" valign="top"> 92/159 (58%)</td>
<td align="center" valign="top"> 162/192 (84%) <sup>†</sup>
</td>
</tr>
</tbody>
</table>